Coventry University Featured PhD Programmes
Norwich Research Park Featured PhD Programmes
The Francis Crick Institute Featured PhD Programmes
Norwich Research Park Featured PhD Programmes
Cardiff University Featured PhD Programmes
"immunotherapy"×
10 miles

immunotherapy PhD Projects, Programs & Scholarships

We have 27 immunotherapy PhD Projects, Programs & Scholarships

  • "immunotherapy" ×
  • clear all
Order by 
Showing 1 to 10 of 27
  Enhancing Oncolytic Virus-induced Immunotherapy using Eicosapentaenoic Acid (EPA)
  Dr F Errington-Mais, Dr MA Volpato
Applications accepted all year round

Funding Type

PhD Type

Breast cancer is the most commonly diagnosed cancer in women with triple-negative breast cancer (TNBC) having the worst prognosis, highest death rate and lowest overall survival.
  Expanded potential stem cells for regenerative medicine, immunotherapy, and biotechnology
  Prof P Liu
Applications accepted all year round

Funding Type

PhD Type

Embryonic stem cells (ES cells) and induced pluripotent stem cells (iPS cells) are pluripotent and thus hold great promise in regenerative medicine, studying disease mechanisms and drug discovery.
  Using viral vectors to generate killer cells for immunotherapy against cancer and pathogens
  Dr E Wang, Dr M Heurich-Sevcenco
Application Deadline: 25 November 2019

Funding Type

PhD Type

The ‘GW4 BioMed MRC DTP’ is awarding up to 18 studentships with an October 2020 start date, aligned with the themes of Infection, Immunity and Repair; Neuroscience and Mental Health; and Population Health.
  Radiation induced oxidative DNA damage and cancer immunology in NSCLC
  Dr C Hiley, Dr S Boulton
Application Deadline: 29 November 2019

Funding Type

PhD Type

Forty percent of all patients cured of cancer have radiotherapy as part of their treatment. Lung cancer is the most common cause of cancer death in the UK and in non-small cell lung cancer (NSCLC) radiotherapy is the standard of care for patients with stage III disease.
  A multiple modality approach for targeting treatment-resistant ovarian cancer
  Dr E. Sanij, Prof R. Pearson
Applications accepted all year round

Funding Type

PhD Type

High-grade serous ovarian cancer (HGSOC) accounts for 70% of ovarian cancer (OvCa) deaths and its five-year survival rate is 43%.
  Defining the microbiome environment in patients with biliary tract cancer and its implications for therapy
  Prof J W Valle, Dr M McNamara
Applications accepted all year round

Funding Type

PhD Type

Biliary tract cancers (BTCs) encompass cancers of the extrahepatic/intrahepatic bile ducts, gallbladder and ampullary carcinoma. The only potentially curative option is surgical resection; median overall survival (OS) in the advanced setting.
  Neutrophils and Chemokine Signalling in the Tumour Immune Micro-environment and Progression
  Dr T Iwata
Applications accepted all year round

Funding Type

PhD Type

Checkpoint inhibitor immunotherapy is promising, however still requires an improvement in response and development of markers to predict the patients who would benefit from this therapy.
  Image guided focused ultrasound to enhance efficacy of cancer therapeutics
  Dr M Thanou, Dr N Saffari
Application Deadline: 29 November 2019

Funding Type

PhD Type

Biological therapies, such anti-PD-1 checkpoint inhibitor, have been found to effectively treat certain cancers, but they minimally affect others.
  Using T cells to eradicate cancer
  Prof T. Tiganis
Applications accepted all year round

Funding Type

PhD Type

The Tiganis Laboratory is seeking a highly enthusiastic student to conduct research in immuno-oncology and the development of novel immunotherapeutic approaches for the treatment of cancer.
  Stochastic Multiscale Model of Evolutionary Competition of Molecules
  Dr F Spill
Applications accepted all year round

Funding Type

PhD Type

Oligonucleotides are not only the careers of genetic information. They can also form complex 3D structures with diverse chemical properties.
Show 10 15 30 per page


FindAPhD. Copyright 2005-2019
All rights reserved.